Arthur R. McGivern Named Executive Vice President and General Counsel of Royalty Pharma

Arthur R. McGivern was promoted to Executive Vice President and General Counsel of Royalty Pharma on December 22, 2025, according to an SEC filing.

NameArthur R. McGivern
RoleExecutive Vice President and General Counsel
CompanyRoyalty Pharma
IndustryBiopharma
LocationNew York, NY
MoveInternal promotion
DateDecember 22, 2025
Sourcean SEC filing

Royalty Pharma said Arthur R. McGivern, its Executive Vice President and General Counsel, will take on the responsibilities of departing Chief Legal Officer George W. Lloyd from January 1, 2026. McGivern joined the company in October 2022 from Goodwin Procter, where he was a partner. (Source: an SEC filing.)

Who is the Executive Vice President and General Counsel of Royalty Pharma?

Arthur R. McGivern took the Executive Vice President and General Counsel role at Royalty Pharma in December 2025, as reported by an SEC filing. Legal leadership changes often, so check Royalty Pharma’s own leadership page for the latest. If you know of a newer move, tell us and we will update the directory.

More legal leadership moves at Royalty Pharma

Other general counsel moves in December 2025

Browse every appointment in the General Counsel Directory.

Source: an SEC filing. InhouseBlog summarizes publicly reported general counsel moves and links to the original report.

Does this information need updating? Email us at info@inhouseblog.com.